07:05 EST Insmed (INSM) sees FY25 revenue $606.4M, consensus $522.03M
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed price target lowered to $157 from $158 at Morgan Stanley
- Insmed price target lowered to $215 from $223 at UBS
- Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
- Insmed assumed with a Buy at Truist
- Insmed: Brinsupri-Led Growth, Pipeline Optionality, and Discounted Valuation Underpin Buy Rating